# US 2023/0398075 A1 · Nanoparticle synthesis systems and methods employing vortex flow focusing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0398075 A1
- Document ID: US20230398075A1
- Status: Published application
- Kind: A1
- Application number: 18/208,507
- Filed: 2023-06-12
- Published: 2023-12-14
- Earliest claimed: 2022-06-10
- Assignees: University of Maryland, College Park
- Applicants: University of Maryland, College Park
- Inventors: Jung Yeon HAN; Donald Lad DEVOE
- Web page: https://patentgrep.com/patent/US20230398075A1

## CPC

- A61K 9/1277: Preparation processes; Proliposomes
- B01F 23/41: Emulsifying
- B01F 25/10: Mixing by creating a vortex flow, e.g. by tangential introduction of flow components
- B01F 33/3011: using a sheathing stream of a fluid surrounding a central stream of a different fluid, e.g. for reducing the cross-section of the central stream or to produce droplets from the central stream
- B01J 13/08: Simple coacervation, i.e. addition of highly hydrophilic material {(combined with spraying B01J13/043; combined with mechanical division B01J13/04)}
- B01F 2025/913: {Vortex flow, i.e. flow spiraling in a tangential direction and moving in an axial direction}
- B01F 2101/22: Mixing of ingredients for pharmaceutical or medical compositions
- B01F 2215/0431: Numerical size values, e.g. diameter of a hole or conduit, area, volume, length, width, or ratios thereof
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B01F: MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING (mixing paints B44D3/06)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

A first inlet flow can be directed along an axial direction in a hydrocyclonic flow cell. The first inlet flow can include first constituent molecules. At a same time, one or more second inlet flows can be directed along a circumferential direction of the hydrocyclonic flow cell. Each second inlet flow can include a buffer solution. The first inlet flow can be subjected to flow focusing by a surrounding primary vortex formed by the one or more second inlet flows, so as to generate a flow comprising a plurality of nanoparticles at an outlet of the hydrocyclonic flow cell. Each nanoparticle can be formed by a respective plurality of the first constituent molecules.

## Claims

### Claim 1

A method for forming a plurality of nanoparticles, the method comprising:
(a) directing a first inlet flow along an axial direction in a hydrocyclonic flow cell, the first inlet flow comprising first constituent molecules; and
(b) at a same time as (a), directing one or more second inlet flows along a circumferential direction of the hydrocyclonic flow cell, each second inlet flow comprising a buffer solution,
wherein the directing of (a) and (b) are such that the first inlet flow is subjected to flow focusing by a surrounding primary vortex formed by the one or more second inlet flows, so as to generate a flow comprising the plurality of nanoparticles at an outlet of the hydrocyclonic flow cell, and
each nanoparticle is formed by a respective plurality of the first constituent molecules.

### Claim 2 (depends on 1)

The method of claim 1, wherein:
the hydrocyclonic flow cell comprises:
a cylindrical portion comprising a circumferentially-extending wall;
an inlet nozzle surrounded by the circumferentially-extending wall of the cylindrical portion and extending toward the outlet; and
a conical portion that extends from an axial end of the circumferentially-extending wall of the cylindrical portion toward the outlet, the conical portion being tapered along at least a portion of its length along the axial direction;
the first inlet flow is directed into the hydrocyclonic flow cell via the inlet nozzle;
each second inlet flow is directed into the cylindrical portion; and
the inlet nozzle and the outlet are substantially co-axial.

### Claim 3 (depends on 2)

The method of claim 2, wherein a radially-outer surface of the inlet nozzle is tapered along at least a portion of its length along the axial direction.

### Claim 4 (depends on 1)

The method of claim 1, further comprising:
(c) at a same time as (a), directing one or more third inlet flows in the hydrocyclonic flow cell, each third inlet flow being adjacent to the first inlet flow along a radial direction of the hydrocyclonic flow cell and comprising second constituent molecules,
wherein the directing of (a), (b), and (c) is such that each nanoparticle comprises the respective plurality of the first constituent molecules and one or more of the second constituent molecules.

### Claim 5 (depends on 4)

The method of claim 4, wherein the second constituent molecules comprise a drug.

### Claim 6 (depends on 4)

The method of claim 4, wherein the one or more third inlet flows comprises an annular flow substantially centered with and surrounding the first inlet flow.

### Claim 7 (depends on 1)

The method of claim 1, wherein:
the first inlet flow comprises second constituent molecules, and
the directing of (a) and (b) are such that each nanoparticle comprises the respective plurality of the first constituent molecules and one or more of the second constituent molecules.

### Claim 8 (depends on 7)

The method of claim 7, wherein the second constituent molecules comprises a drug.

### Claim 9 (depends on 1)

The method of claim 1, wherein:
the one or more second inlet flows comprise second constituent molecules, and
the directing of (a) and (b) are such that each nanoparticle comprises the respective plurality of the first constituent molecules and one or more of the second constituent molecules.

### Claim 10 (depends on 9)

The method of claim 9, wherein the second constituent molecules comprises a drug.

### Claim 11 (depends on 1)

The method of claim 1, wherein the first constituent molecules comprise an organic material or an inorganic material.

### Claim 12 (depends on 1)

The method of claim 1, wherein the first constituent molecules comprise lipids, and each nanoparticle is a liposome or lipid nanoparticle.

### Claim 13 (depends on 12)

The method of claim 12, wherein at least some of the lipids comprise polyethylene glycol (PEG).

### Claim 14 (depends on 1)

The method of claim 1, wherein a flow rate of the first inlet flow and/or a flow rate of the one or more second inlet flows are selected so as to provide predetermined sizes for the plurality of nanoparticles.

### Claim 15 (depends on 1)

The method of claim 1, wherein the directing of (a) and (b) are such that the plurality of nanoparticles are generated at a rate of at least 20 g/h.

### Claim 16 (depends on 1)

The method of claim 1, wherein the generated plurality of nanoparticles have diameters less than or equal to 100 nm and a polydispersity index less than or equal to 0.2.

### Claim 17

A nanoparticle synthesis system comprising:
a hydrocyclonic flow cell comprising:
a cylindrical section comprising a circumferentially-extending wall with one or more tangentially-oriented inlet ports;
an inlet nozzle surrounded by the circumferentially-extending wall of the cylindrical section and providing an axially-oriented inlet port; and
a conical section that extends from an axial end of the circumferentially-extending wall of the cylindrical section toward an axially-oriented outlet port, the conical section being tapered along at least a portion of its length along an axial direction,
wherein the axially-oriented inlet port and the axially-oriented outlet port are substantially co-axial, and
a radially-outer surface of the inlet nozzle is tapered along at least a portion of its length along the axial direction.

### Claim 18 (depends on 17)

The nanoparticle synthesis system of claim 17, wherein:
the hydrocyclonic flow cell further comprises a second inlet nozzle surrounded by the circumferentially-extending wall of the cylindrical section; and
the second inlet nozzle provides an annular port proximal to and substantially centered with the axially-oriented inlet port of the inlet nozzle along a radial direction.

### Claim 19 (depends on 17)

The nanoparticle synthesis system of claim 17, wherein:
(a) a diameter of the axially-oriented inlet port of the inlet nozzle is less than or equal to 500 μm;
(b) a diameter of the axially-oriented outlet port is less than or equal to 500 μm;
(c) a thickness of a wall of the inlet nozzle that defines the axially-oriented inlet port is less than 150 μm along a radial direction; or
any combination of (a)-(c).

### Claim 20 (depends on 17)

The nanoparticle synthesis system of claim 17, further comprising:
a reservoir of buffer solution fluidically coupled to the one or more tangentially-oriented inlet ports; and
a reservoir of lipid solution fluidically coupled to the axially-oriented inlet port of the inlet nozzle.
